An open-label trial of JAK 1/2 blockade in progressive IFIH1-associated neuroinflammation. (6th February 2018) - Kothur, Kavitha; Bandodkar, Sushil; Chu, Stephanie; Wienholt, Louise; Johnson, Alexandra; Barclay, Peter; Brogan, Paul A.; Rice, Gillian I.; Crow, Yanick J.; Dale, Russell C.